Review



cd4 174yb  (fluidigm)


Bioz Verified Symbol fluidigm is a verified supplier
Bioz Manufacturer Symbol fluidigm manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    fluidigm cd4 174yb
    Cd4 174yb, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 15 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3174004b/Anti-Human+CD4+(SK3)-174Yb/pmc12484868__41467_2025_63696_MOESM5_ESM-58-71-78
    Average 93 stars, based on 15 article reviews
    cd4 174yb - by Bioz Stars, 2026-09
    93/100 stars

    Images

    Related Articles

    Recombinase Polymerase Amplification:

    Article Title: Multiomics approaches disclose very-early molecular and cellular switches during insect-venom allergen-specific immunotherapy: an observational study
    Article Snippet: .. The list of CyTOF Abs used in this work: Metal Isotope, Antibody, Ab Amount (μl), Clone, Manufacturer, Catalogue#, LOT# (whenever available; if more than one LOT was used, they are split by '&') 154Sm CD3, 1, UCHT1, Fluidigm, 3154003B, 0151806 174Yb CD4, 1, SK3, Fluidigm, 3174004B, 2351715 146Nd CD8a, 1, RPA-T8, Fluidigm, 3146001B,1671716 209Bi CD11b, 1, ICRF44, Fluidigm, 3209003B, 0831723 160Gd CD14, 1, M5E2, Fluidigm, 3160001B, 3261702 164Dy CD15 (SSEA-1), 1, W6D3, Fluidigm, 3164001B, 1421725 148Nd CD16, 1, 3G8, Fluidigm, 3148004B, 2511709 142Nd CD19, 1, HIB19, Fluidigm, 3142001B, 0171815 147Sm CD20, 1, 2H7, Fluidigm, 3147001B, 2491705 166Er CD24, 1, ML5, Fluidigm, 3166007B, 2651709 149Sm CD25 (IL-2R), 1, 2A3, Fluidigm, 3149010B, 1931712 6 nature portfolio | rep orting sum m ary April2023 167Er CD27, 1, L128, Fluidigm, 3167006B, 3501404 172Yb CD38, 1, HIT2, Fluidigm, 3172007B, 1931716 171Yb CD44, 0.1, IM7, Fluidigm, 3171003B, 1931725 & 3421608 89Y CD45, 1, HI30, Fluidigm, 3089003B, 3421702 165Ho CD45RO, 1, UCHL1, Fluidigm, 3165011B, 1421721 153Eu CD45RA, 1, HI100, Fluidigm, 3153001B, 0641506 & 641506 155Gd CD56 (NCAM), 1, B159, Fluidigm, 3155008B, 2771704 & 1471501 150Nd CD63, 1, H5C6, Fluidigm, 3150021B, 1801513 152Sm CD66b, 1, 80H3, Fluidigm, 3152011B, 3491401 144Nd CD69, 1, FN50, Fluidigm, 3144018B, 3041705 143Nd CD117 (cKit), 1, 104D2, Fluidigm, 3143001B, 1711722 151Eu CD123 (IL-3R), 1, 6H6, Fluidigm, 3151001B, 2291711 168Er CD127 (IL-7a), 1, A019D5, Fluidigm, 3168017B, 0541706 145Nd CD138, 1, DL-101, Fluidigm, 3145003B, 2651706 159Tb CD161, 1, HP-3G10, Fluidigm, 3159004B, 1361705 156Gd CD183 (CXCR3), 1, G025H7, Fluidigm, 3156004B, 2771708 175Lu CD194 (CCR4)#, 1, 205410, Fluidigm, 3175021A, 2791705 141Pr CD196 (CCR6), 1, 11A9, Fluidigm, 3141014A, 0751705 163Dy CD294 (CRTH2), 1, BM16, Fluidigm, 3163003B, 1671717 & 691605 170Er HLA-DR, 1, L243, Fluidigm, 3170013B, 3571502 161Dy CD152 (CTLA4), 1, 14D3, Fluidigm, 3161004B, 2651711 169Tm CD30*, 1, 81337, R&D, MAB229, Not available 158Gd CD11c*, 1, 3.9, Biolegend, 301639, Not available 173Yb FceR1/ FCER1A*, 1, AER-37 (CRA1), Thermo Fisher Scientific, 16-5899-82, Not available 176Yb TCR*, 1, B1.1, Thermo Fisher Scientific, 16-9959-81, Not available Notes, * in-house conjugation using Maxpar X8 Antibody Labeling Kits. ..

    Conjugation Assay:

    Article Title: Multiomics approaches disclose very-early molecular and cellular switches during insect-venom allergen-specific immunotherapy: an observational study
    Article Snippet: .. The list of CyTOF Abs used in this work: Metal Isotope, Antibody, Ab Amount (μl), Clone, Manufacturer, Catalogue#, LOT# (whenever available; if more than one LOT was used, they are split by '&') 154Sm CD3, 1, UCHT1, Fluidigm, 3154003B, 0151806 174Yb CD4, 1, SK3, Fluidigm, 3174004B, 2351715 146Nd CD8a, 1, RPA-T8, Fluidigm, 3146001B,1671716 209Bi CD11b, 1, ICRF44, Fluidigm, 3209003B, 0831723 160Gd CD14, 1, M5E2, Fluidigm, 3160001B, 3261702 164Dy CD15 (SSEA-1), 1, W6D3, Fluidigm, 3164001B, 1421725 148Nd CD16, 1, 3G8, Fluidigm, 3148004B, 2511709 142Nd CD19, 1, HIB19, Fluidigm, 3142001B, 0171815 147Sm CD20, 1, 2H7, Fluidigm, 3147001B, 2491705 166Er CD24, 1, ML5, Fluidigm, 3166007B, 2651709 149Sm CD25 (IL-2R), 1, 2A3, Fluidigm, 3149010B, 1931712 6 nature portfolio | rep orting sum m ary April2023 167Er CD27, 1, L128, Fluidigm, 3167006B, 3501404 172Yb CD38, 1, HIT2, Fluidigm, 3172007B, 1931716 171Yb CD44, 0.1, IM7, Fluidigm, 3171003B, 1931725 & 3421608 89Y CD45, 1, HI30, Fluidigm, 3089003B, 3421702 165Ho CD45RO, 1, UCHL1, Fluidigm, 3165011B, 1421721 153Eu CD45RA, 1, HI100, Fluidigm, 3153001B, 0641506 & 641506 155Gd CD56 (NCAM), 1, B159, Fluidigm, 3155008B, 2771704 & 1471501 150Nd CD63, 1, H5C6, Fluidigm, 3150021B, 1801513 152Sm CD66b, 1, 80H3, Fluidigm, 3152011B, 3491401 144Nd CD69, 1, FN50, Fluidigm, 3144018B, 3041705 143Nd CD117 (cKit), 1, 104D2, Fluidigm, 3143001B, 1711722 151Eu CD123 (IL-3R), 1, 6H6, Fluidigm, 3151001B, 2291711 168Er CD127 (IL-7a), 1, A019D5, Fluidigm, 3168017B, 0541706 145Nd CD138, 1, DL-101, Fluidigm, 3145003B, 2651706 159Tb CD161, 1, HP-3G10, Fluidigm, 3159004B, 1361705 156Gd CD183 (CXCR3), 1, G025H7, Fluidigm, 3156004B, 2771708 175Lu CD194 (CCR4)#, 1, 205410, Fluidigm, 3175021A, 2791705 141Pr CD196 (CCR6), 1, 11A9, Fluidigm, 3141014A, 0751705 163Dy CD294 (CRTH2), 1, BM16, Fluidigm, 3163003B, 1671717 & 691605 170Er HLA-DR, 1, L243, Fluidigm, 3170013B, 3571502 161Dy CD152 (CTLA4), 1, 14D3, Fluidigm, 3161004B, 2651711 169Tm CD30*, 1, 81337, R&D, MAB229, Not available 158Gd CD11c*, 1, 3.9, Biolegend, 301639, Not available 173Yb FceR1/ FCER1A*, 1, AER-37 (CRA1), Thermo Fisher Scientific, 16-5899-82, Not available 176Yb TCR*, 1, B1.1, Thermo Fisher Scientific, 16-9959-81, Not available Notes, * in-house conjugation using Maxpar X8 Antibody Labeling Kits. ..

    Antibody Labeling:

    Article Title: Multiomics approaches disclose very-early molecular and cellular switches during insect-venom allergen-specific immunotherapy: an observational study
    Article Snippet: .. The list of CyTOF Abs used in this work: Metal Isotope, Antibody, Ab Amount (μl), Clone, Manufacturer, Catalogue#, LOT# (whenever available; if more than one LOT was used, they are split by '&') 154Sm CD3, 1, UCHT1, Fluidigm, 3154003B, 0151806 174Yb CD4, 1, SK3, Fluidigm, 3174004B, 2351715 146Nd CD8a, 1, RPA-T8, Fluidigm, 3146001B,1671716 209Bi CD11b, 1, ICRF44, Fluidigm, 3209003B, 0831723 160Gd CD14, 1, M5E2, Fluidigm, 3160001B, 3261702 164Dy CD15 (SSEA-1), 1, W6D3, Fluidigm, 3164001B, 1421725 148Nd CD16, 1, 3G8, Fluidigm, 3148004B, 2511709 142Nd CD19, 1, HIB19, Fluidigm, 3142001B, 0171815 147Sm CD20, 1, 2H7, Fluidigm, 3147001B, 2491705 166Er CD24, 1, ML5, Fluidigm, 3166007B, 2651709 149Sm CD25 (IL-2R), 1, 2A3, Fluidigm, 3149010B, 1931712 6 nature portfolio | rep orting sum m ary April2023 167Er CD27, 1, L128, Fluidigm, 3167006B, 3501404 172Yb CD38, 1, HIT2, Fluidigm, 3172007B, 1931716 171Yb CD44, 0.1, IM7, Fluidigm, 3171003B, 1931725 & 3421608 89Y CD45, 1, HI30, Fluidigm, 3089003B, 3421702 165Ho CD45RO, 1, UCHL1, Fluidigm, 3165011B, 1421721 153Eu CD45RA, 1, HI100, Fluidigm, 3153001B, 0641506 & 641506 155Gd CD56 (NCAM), 1, B159, Fluidigm, 3155008B, 2771704 & 1471501 150Nd CD63, 1, H5C6, Fluidigm, 3150021B, 1801513 152Sm CD66b, 1, 80H3, Fluidigm, 3152011B, 3491401 144Nd CD69, 1, FN50, Fluidigm, 3144018B, 3041705 143Nd CD117 (cKit), 1, 104D2, Fluidigm, 3143001B, 1711722 151Eu CD123 (IL-3R), 1, 6H6, Fluidigm, 3151001B, 2291711 168Er CD127 (IL-7a), 1, A019D5, Fluidigm, 3168017B, 0541706 145Nd CD138, 1, DL-101, Fluidigm, 3145003B, 2651706 159Tb CD161, 1, HP-3G10, Fluidigm, 3159004B, 1361705 156Gd CD183 (CXCR3), 1, G025H7, Fluidigm, 3156004B, 2771708 175Lu CD194 (CCR4)#, 1, 205410, Fluidigm, 3175021A, 2791705 141Pr CD196 (CCR6), 1, 11A9, Fluidigm, 3141014A, 0751705 163Dy CD294 (CRTH2), 1, BM16, Fluidigm, 3163003B, 1671717 & 691605 170Er HLA-DR, 1, L243, Fluidigm, 3170013B, 3571502 161Dy CD152 (CTLA4), 1, 14D3, Fluidigm, 3161004B, 2651711 169Tm CD30*, 1, 81337, R&D, MAB229, Not available 158Gd CD11c*, 1, 3.9, Biolegend, 301639, Not available 173Yb FceR1/ FCER1A*, 1, AER-37 (CRA1), Thermo Fisher Scientific, 16-5899-82, Not available 176Yb TCR*, 1, B1.1, Thermo Fisher Scientific, 16-9959-81, Not available Notes, * in-house conjugation using Maxpar X8 Antibody Labeling Kits. ..

    Virus:

    Article Title: Anatomical, subset, and HIV-dependent expression of viral sensors and restriction factors.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies CD57 Biolegend Cat#359602; RRID:AB_2562403 HLADR Thermo Fisher Scientific Cat#Q22158; RRID:AB_2556514 CD25 BD Biosciences Cat#555430; RRID:AB_395824 CD19 Standard BioTools Cat#3142001B; RRID:AB_3661857 IFI16 Santa Cruz Biotechnology Cat#sc-8023; RRID:AB_627775 CCR5 Standard BioTools Cat#3144007A; RRID:AB_2892770 IFITM1 Proteintech Cat#60074-1-Ig; RRID:AB_2233405 CD8 Standard BioTools Cat#3146001B; RRID:AB_3661846 cGAS Cell Signaling Technology Cat#79978S; RRID:AB_2905508 IFIT3 Novus Cat#NBP2-71006; RRID:AB_3094693 AIM2 Santa Cruz Biotechnology Cat#sc-293174; RRID:AB_3665129 HSA (CD24) Standard BioTools Cat#3150009B; RRID:AB_2916042 LAG3 Standard BioTools Cat#3150030B; RRID:AB_3661851 pSTING Cell Signaling Technology Cat#40818; RRID:AB_2799187 SLFN11 Santa Cruz Biotechnology Cat#sc-374339; RRID:AB_10989536 MX2 Santa Cruz Biotechnology Cat#sc-271527; RRID:AB_10649506 IFIT1 Novus Cat#NBP2-71005; RRID:AB_3363102 pIRF3 Cell Signaling Technology Cat#29047; RRID:AB_2773013 SAMHD1 Proteintech Cat#12586-1-AP; RRID:AB_2183496 TRIM28 R and D Systems Cat#MAB7785; RRID:AB_3096992 PAF1 Santa Cruz Biotechnology Cat#sc-514491; RRID:AB_3665128 CCR7 Standard BioTools Cat#3159003A; RRID:AB_2938859 MX1 Cell Signaling Technology Cat#62815; RRID:AB_3665127 CD45RO Biolegend Cat#304239; RRID:AB_2563752 CD69 Standard BioTools Cat#3162001B; RRID:AB_3096016 TLR9 Novus Cat#NBP2-24729; RRID:AB_3272891 CXCR5 Standard BioTools Cat#3164029B; RRID:AB_3665126 pSAMHD1 Sigma-Aldrich Cat#MABF934; RRID:AB_3665125 PQBP1 Santa Cruz Biotechnology Cat#sc-376039; RRID:AB_10989350 CD27 Standard BioTools Cat#3167002B; RRID:AB_3094744 PD1 BD Biosciences Cat#562138; RRID:AB_10897007 CD45RA Standard BioTools Cat#3169008B; RRID:AB_3665124 CD3 Standard BioTools Cat#3170001B; RRID:AB_2811085 RIGI Novus Cat#NBP2-61849; RRID:AB_3351257 CD38 Standard BioTools Cat#3172007B; RRID:AB_2756288 BRD4 Abcam Catab182446; RRID:AB_3665123 CD4 Standard BioTools Cat3174004B; RRID:AB_3661864 CD14 Biolegend Cat#301843; RRID:AB_2562813 CD127 Standard BioTools Cat#3176004B; RRID:AB_3665122 TIGIT Standard BioTools Cat#3209013B; RRID:AB_2905649 Bacterial and virus strains HIV-F4.HSA (NL-HSA.6ATRi-C.109FPB4.ecto) Cavrois et al.34 N/A HIV-F4.HSA virions containing BlaM-Vpr Cavrois et al.34,67 N/A (Continued on next page) 16 Cell Reports 44, 115202, January 28, 2025 .. REAGENT or RESOURCE SOURCE IDENTIFIER GraphPad Prism (Version 10.2.0) http://www.graphpad.com/ RRID:SCR_002798 RStudio (2022.07.2 + 576 "Spotted Wakerobin" Release) https://rstudio.com/ RRID:SCR_000432 R Project for Statistical Computing (Version 4.2.1) http://www.r-project.org/ RRID:SCR_001905 CUHIMSR/CytofBatchAdjust Schuyler et al.95; https://github.com/ CUHIMSR/CytofBatchAdjust N/A ggplot2 https://cran.r-project.org/web/ packages/ggplot2/index.html RRID:SCR_014601 Rtsne https://github.com/jkrijthe/Rtsne RRID:SCR_016342 Seurat Hao et al.96; https://satijalab.org/ seurat/get_started.html RRID:SCR_016341 Harmony Korsunsky et al.97; https://github.com/ immunogenomics/harmony RRID:SCR_022206 RandomForest Package in R Breiman98; https://cran.r-project. org/web/packages/randomForest/ RRID:SCR_015718 lme4 Bates et al.99; https://cran.r-project. org/web/packages/lme4/index.html RRID:SCR_015654 emmeans https://CRAN.R-project.org/ package=emmeans RRID:SCR_018734

    other:

    Article Title: Inflammatory bone marrow signaling in pediatric acute myeloid leukemia distinguishes patients with poor outcomes
    Article Snippet: The table below provides the Label ,Target ,Clone, Cocktail ,Vendor, and Catalog Number of all antibodies used for CyTOF in comma separated format: Label, Target, Clone, Cocktail, Vendor, Catalog Number 89Y, CD45, HI30, Surface, Standard BioTools, 3089003B 141Pr, CD3, UCHT1, Surface, Standard BioTools, 3141019B 142Nd, TLR4, HTA125, Surface, Biolegend*, 312802 143Nd, CD123, 6H6, Surface, Standard BioTools, 3143014B 5 n atu re p o rtfo lio | rep o rtin g su m m ary M a rch 2021 Validation Eukaryotic cell lines Policy information about cell lines and Sex and Gender in Research Cell line source(s) Authentication Mycoplasma contamination Commonly misidentified lines (See ICLAC register) 144Nd, FceR1, AER-37, Surface, Biolegend*, 334602 145Nd, CD16, 3G8, Surface, Standard BioTools, 3145008B 146Nd, CD8, RPA-T8, Surface, Standard BioTools, 3146001B 147Sm, CD11c, Bu15, Surface, Standard BioTools, 3147008B 148Nd, CD34, 581, Surface, Standard BioTools, 3148001B 149Sm, CD25, 2A3, Surface, Standard BioTools, 3149010B 150Nd, pSTAT5, 47, Intracellular, Standard BioTools, 3150005A 151Eu, CD14, M5E2, Surface, Standard BioTools, 3151009B 152Sm, CD66b, 80H3, Surface, Standard BioTools, 3152011B 153Eu, pSTAT1, 58D6, Intracellular, Standard BioTools, 3153003A 154Sm, CD10, HI10a, Surface, Biolegend*, 312202 155Gd, CD27, L128, Surface, Standard BioTools, 3155001B 156Gd, p38, D3F9, Intracellular, Standard BioTools, 3156002A 158Gd, pSTAT3, 4/P-Stat3, Intracellular, Standard BioTools, 3158005A 159Tb, CD68, Y1/48A, Intracellular, Standard BioTools, 3171011B 160Gd, TLR8, S16018A, Intracellular, Biolegend*, 395502 161Dy, CD20, H1, Intracellular, Standard BioTools, 3161029D 162Dy, Foxp3, PCH101, Intracellular, Standard BioTools, 3162011A 163Dy, CD33, p67.6, Surface, Biolegend*, 366602 164Dy, I$#", L35A5, Intracellular, Standard BioTools, 3164004A 165Ho, CD19, HIB19, Surface, Standard BioTools, 3165025B 166Er, pNFkBp65, K10895.12.50, Intracellular, Standard BioTools, 3166006A 167Er, CD38, HIT2, Surface, Standard BioTools, 3167001B 168Er, CD73, AD2, Surface, Standard BioTools, 3168015B 169Tm, CD45RA, HI100, Surface, Standard BioTools, 3169008B 170Er, CD117, 104D2, Surface, Biolegend*, 313202 171Yb, pERK1/2, D13.14.4E, Intracellular, Standard BioTools, 3171010A 172Yb, CD15, W6D3, Intracellular, Standard BioTools, 3172021B 173Yb, HLA-DR, L243, Surface, Standard BioTools, 3173005B 174Yb, CD4, SK3, Surface, Standard BioTools, 3174004B 175Lu, pS6, N7-548, Intracellular, Standard BioTools, 3175009A 176Yb, CD56, HCD56, Surface, Standard BioTools, 3176008B 209Bi, CD11b, ICRF44, Intracellular, Standard BioTools, 3209003B * Unlabeled purified antibodies were conjugated to metal isotopes using Maxpar X8 Antibody Labelling Kits (Standard BioTools) as per manufacturer's instructions.

    Article Title: Maturation of the Human Intestinal Immune System Occurs Early in Fetal Development.
    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER CD11b-167Er; ICRF44 Fluidigm Cat #3167011B; RRID:AB_2810974 IL-17a-169Tm; BL168* BioLegend Cat #512331; RRID:AB_2563779 IL-8-170Er; 6217* R&D Systems Cat #MAB208; RRID:AB_2249110 IL-21-172Yb; 3A3-N2 Fluidigm Cat #3172011B; RRID:AB_2810975 IL-10-176Yb; JES3-19F1* BioLegend Cat #506802; RRID:AB_315452 CCR7-BV421; 150503 BD Biosciences Cat #562555; RRID:AB_2728119 CD3-PE-Cy7; SK7 BioLegend Cat #344816; RRID:AB_10640737 CD4-APC-H7; RPA-T4 BD Biosciences Cat #560158; RRID:AB_1645478 CD8-PerCP-Cy5.5; RPA-T8 eBioscience Cat #45-0088-41; RRID:AB_1582256 CD45RA-FITC; HI100 BD Biosciences Cat #555488; RRID:AB_395879 CD45-BV785; HI30 BioLegend Cat #304048; RRID:AB_2563129 CD69-PE; FN50 BioLegend Cat #310906; RRID:AB_314841 Biological Samples Pitt Biospecimen Core University of Pittsburgh http://www.pittbiospecimencore.pitt.edu/ Chemicals, Peptides, and Recombinant Proteins Low-Barium PBS Sigma-Aldrich Cat #D8357 Bovine Serum Albumin, Protease-Free Sigma-Aldrich Cat #A3059 Sodium Azide Sigma-Aldrich Cat #71289 Cell-ID Intercalator-103Rh Fluidigm Cat #201103A Dimethyl Sulfoxide (DMSO) Fisher Scientific Cat #BP231-1; CAS:67-68-5 RPMI (1X) Media Gibco Cat #11875-093 GlutaMAX (100X) Gibco Cat #35050-061 HEPES (1M) Gibco Cat #15630-080 MEM NEAA (100X) Gibco Cat #11140-050 Na Pyruvate (100mM) Gibco Cat #11360-070 Penicillin/Streptomycin Gibco Cat #15140-122 Golgi Stop BD Biosciences Cat #554724 Golgi Plug BD Biosciences Cat #555029 Human Trustain FcX BioLegend Cat #422302 Cell Acquisition Solution Fluidigm Cat #201240 CD69 RNAScope Probe on Channel 2 ACD Bio Cat # 494471-C2 CD3 RNAScope Probe on Channel 1 ACD Bio Cat #553971-C1 Ionomycin Calcium Salt from Streptomyces conglobatus Sigma-Aldrich Cat #I0634 Phorbol 12-Myristate 13-Acetate (PMA) Sigma-Aldrich Cat #P8139 FoxP3 Fix and Perm Buffer A Thermo Fisher Scientific Cat #00-5123-43 FoxP3 Fix and Perm Buffer B Thermo Fisher Scientific Cat #00-5223-56 FoxP3 Wash Buffer Thermo Fisher Scientific Cat #A24261 Formaldehyde Solution Sigma-Aldrich Cat #F8775 DNase I Roche Cat #11284932001 Collagenase A Sigma-Aldrich Cat #10103586001 Fetal Bovine Serum Corning Cat #35-011-CV Cell-ID Intercalator-Ir Fluidigm Cat #201192A Maxpar Fix and Perm Buffer Fluidigm Cat #201067 Critical Commercial Assays RNAscope 2.5 HD Duplex Reagent Kit Advanced Cell Diagnostics Cat #322430 Wizard Genomic DNA Purification Kit Promega Cat #A1120 (Continued on next page) Developmental Cell 51, 1–17.e1–e5, November 4, 2019 e2

    Article Title: The COVIDome Explorer researcher portal
    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER V-PLEX Angiogenesis Panel 1 Human Kit Meso Scale Discovery (MSD) Cat# K15190D PAXgene Blood RNA Tubes PreAnalytiX/QIAGEN Cat# 762165 PAXgene Blood RNA Kit QIAGEN Cat# 762164 Universal Plus mRNA-Seq with NuQuant; Human Globin AnyDeplete Tecan Cat# 0521-A01 Deposited data RNaseq This paper NCBI Gene Expression Omnibus GSE167000 Proteomics (mass spectrometry) This paper PRIDE Partner Repository; entry PXD022817 SOMAscan Proteomics; MSD Cytokine Profiles; and Sample Metadata This paper Mendeley; https://doi.org/10.17632/2mc6rrc5j3.1 Metabolomics data This paper Metabolome Workbench; Project ID PR001110 Mass cytometry data This paper Flow Repository: https://flowrepository.org/ id/RvFrSYioKeUdYHXdkTD9TQPAXt4Pq dkB5eie82h11JgAGSCQIneLKpcKd81Nzgwq.



    Similar Products

    93
    fluidigm cd4 174yb
    Cd4 174yb, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3174004b/Anti-Human+CD4+(SK3)-174Yb/pmc12484868__41467_2025_63696_MOESM5_ESM-58-71-78
    Average 93 stars, based on 1 article reviews
    cd4 174yb - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    fluidigm 174 yb conjugated mouse anti human cd4
    174 Yb Conjugated Mouse Anti Human Cd4, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3174004b/Anti-Human+CD4+(SK3)-174Yb/pmc12583509-64-0-6
    Average 93 stars, based on 1 article reviews
    174 yb conjugated mouse anti human cd4 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    fluidigm anti cd4 sk3 fluidigm
    Anti Cd4 Sk3 Fluidigm, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3174004b/Anti-Human+CD4+(SK3)-174Yb/pmc10103532__12929_2023_916_MOESM1_ESM-0-73-75
    Average 93 stars, based on 1 article reviews
    anti cd4 sk3 fluidigm - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    fluidigm 3174004b rrid ab 3661864
    KEY RESOURCES TABLE
    3174004b Rrid Ab 3661864, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3174004b/Anti-Human+CD4+(SK3)-174Yb/pmc11829653-37-5-2
    Average 93 stars, based on 1 article reviews
    3174004b rrid ab 3661864 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    fluidigm cd4
    (A) Spleen, lymph node (LN), gut, male reproductive tract, kidney, liver, bone marrow (BM), heart, and lung were harvested postmortem from antiretroviral therapy (ART)-treated people with HIV (PWH; N = 7) and analyzed by VISOR-CyTOF. Sample sizes for individual tissues are indicated. Total numbers of immune, myeloid, B cells, <t>CD4</t> + T, and CD8 + T cells analyzed are shown. Created with BioRender.com . (B and C) VISOR-CyTOF distinguishes myeloid, B, and naive and memory CD4 + and CD8 + T cells from tissues and blood. Immune cells from the tissues of PWH as described in panel (A) (B) and PBMCs from people without HIV (PWOH; N = 4 participants) (C) were phenotyped by VISOR-CyTOF and visualized by tSNE using all markers in the panel. (D and E) tSNE analysis using only VISOR markers of VISOR-CyTOF separates myeloid, B, and T cells from one another. Data from the tissues from PWH (D) and PBMCs from PWOH (E) are shown. In (B)–(E), overlaid tSNEs are shown on the left, while tSNEs separated out by each immune subset are shown on the right. Abbreviations: Tm, memory T cells; Tn, naive T cells.
    Cd4, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3174004b/Anti-Human+CD4+(SK3)-174Yb/pmc11829653-37-0-2
    Average 93 stars, based on 1 article reviews
    cd4 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    fluidigm 3174004b
    (A) Spleen, lymph node (LN), gut, male reproductive tract, kidney, liver, bone marrow (BM), heart, and lung were harvested postmortem from antiretroviral therapy (ART)-treated people with HIV (PWH; N = 7) and analyzed by VISOR-CyTOF. Sample sizes for individual tissues are indicated. Total numbers of immune, myeloid, B cells, <t>CD4</t> + T, and CD8 + T cells analyzed are shown. Created with BioRender.com . (B and C) VISOR-CyTOF distinguishes myeloid, B, and naive and memory CD4 + and CD8 + T cells from tissues and blood. Immune cells from the tissues of PWH as described in panel (A) (B) and PBMCs from people without HIV (PWOH; N = 4 participants) (C) were phenotyped by VISOR-CyTOF and visualized by tSNE using all markers in the panel. (D and E) tSNE analysis using only VISOR markers of VISOR-CyTOF separates myeloid, B, and T cells from one another. Data from the tissues from PWH (D) and PBMCs from PWOH (E) are shown. In (B)–(E), overlaid tSNEs are shown on the left, while tSNEs separated out by each immune subset are shown on the right. Abbreviations: Tm, memory T cells; Tn, naive T cells.
    3174004b, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3174004b/Anti-Human+CD4+(SK3)-174Yb/pm39798087-254-193-191
    Average 93 stars, based on 1 article reviews
    3174004b - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    fluidigm 0151806 174yb cd4
    (A) Spleen, lymph node (LN), gut, male reproductive tract, kidney, liver, bone marrow (BM), heart, and lung were harvested postmortem from antiretroviral therapy (ART)-treated people with HIV (PWH; N = 7) and analyzed by VISOR-CyTOF. Sample sizes for individual tissues are indicated. Total numbers of immune, myeloid, B cells, <t>CD4</t> + T, and CD8 + T cells analyzed are shown. Created with BioRender.com . (B and C) VISOR-CyTOF distinguishes myeloid, B, and naive and memory CD4 + and CD8 + T cells from tissues and blood. Immune cells from the tissues of PWH as described in panel (A) (B) and PBMCs from people without HIV (PWOH; N = 4 participants) (C) were phenotyped by VISOR-CyTOF and visualized by tSNE using all markers in the panel. (D and E) tSNE analysis using only VISOR markers of VISOR-CyTOF separates myeloid, B, and T cells from one another. Data from the tissues from PWH (D) and PBMCs from PWOH (E) are shown. In (B)–(E), overlaid tSNEs are shown on the left, while tSNEs separated out by each immune subset are shown on the right. Abbreviations: Tm, memory T cells; Tn, naive T cells.
    0151806 174yb Cd4, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3174004b/Anti-Human+CD4+(SK3)-174Yb/pmc11599746__41467_2024_54684_MOESM2_ESM-152-39-44
    Average 93 stars, based on 1 article reviews
    0151806 174yb cd4 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    fluidigm sk3
    (A) Spleen, lymph node (LN), gut, male reproductive tract, kidney, liver, bone marrow (BM), heart, and lung were harvested postmortem from antiretroviral therapy (ART)-treated people with HIV (PWH; N = 7) and analyzed by VISOR-CyTOF. Sample sizes for individual tissues are indicated. Total numbers of immune, myeloid, B cells, <t>CD4</t> + T, and CD8 + T cells analyzed are shown. Created with BioRender.com . (B and C) VISOR-CyTOF distinguishes myeloid, B, and naive and memory CD4 + and CD8 + T cells from tissues and blood. Immune cells from the tissues of PWH as described in panel (A) (B) and PBMCs from people without HIV (PWOH; N = 4 participants) (C) were phenotyped by VISOR-CyTOF and visualized by tSNE using all markers in the panel. (D and E) tSNE analysis using only VISOR markers of VISOR-CyTOF separates myeloid, B, and T cells from one another. Data from the tissues from PWH (D) and PBMCs from PWOH (E) are shown. In (B)–(E), overlaid tSNEs are shown on the left, while tSNEs separated out by each immune subset are shown on the right. Abbreviations: Tm, memory T cells; Tn, naive T cells.
    Sk3, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3174004b/Anti-Human+CD4+(SK3)-174Yb/pmc11599746__41467_2024_54684_MOESM2_ESM-152-43-44
    Average 93 stars, based on 1 article reviews
    sk3 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    fluidigm cd4 sk3 3174004b 174yb standard biotools
    (A) Spleen, lymph node (LN), gut, male reproductive tract, kidney, liver, bone marrow (BM), heart, and lung were harvested postmortem from antiretroviral therapy (ART)-treated people with HIV (PWH; N = 7) and analyzed by VISOR-CyTOF. Sample sizes for individual tissues are indicated. Total numbers of immune, myeloid, B cells, <t>CD4</t> + T, and CD8 + T cells analyzed are shown. Created with BioRender.com . (B and C) VISOR-CyTOF distinguishes myeloid, B, and naive and memory CD4 + and CD8 + T cells from tissues and blood. Immune cells from the tissues of PWH as described in panel (A) (B) and PBMCs from people without HIV (PWOH; N = 4 participants) (C) were phenotyped by VISOR-CyTOF and visualized by tSNE using all markers in the panel. (D and E) tSNE analysis using only VISOR markers of VISOR-CyTOF separates myeloid, B, and T cells from one another. Data from the tissues from PWH (D) and PBMCs from PWOH (E) are shown. In (B)–(E), overlaid tSNEs are shown on the left, while tSNEs separated out by each immune subset are shown on the right. Abbreviations: Tm, memory T cells; Tn, naive T cells.
    Cd4 Sk3 3174004b 174yb Standard Biotools, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3174004b/Anti-Human+CD4+(SK3)-174Yb/pmc10834368__41590_2023_1724_MOESM1_ESM-15-269-273
    Average 93 stars, based on 1 article reviews
    cd4 sk3 3174004b 174yb standard biotools - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    KEY RESOURCES TABLE

    Journal: Cell reports

    Article Title: Anatomical, subset, and HIV-dependent expression of viral sensors and restriction factors

    doi: 10.1016/j.celrep.2024.115202

    Figure Lengend Snippet: KEY RESOURCES TABLE

    Article Snippet: CD4 , Standard BioTools , Cat3174004B; RRID:AB_3661864.

    Techniques: Virus, Recombinant, Electron Microscopy, Clinical Proteomics, Modification, Antibody Labeling, Staining, Software

    (A) Spleen, lymph node (LN), gut, male reproductive tract, kidney, liver, bone marrow (BM), heart, and lung were harvested postmortem from antiretroviral therapy (ART)-treated people with HIV (PWH; N = 7) and analyzed by VISOR-CyTOF. Sample sizes for individual tissues are indicated. Total numbers of immune, myeloid, B cells, CD4 + T, and CD8 + T cells analyzed are shown. Created with BioRender.com . (B and C) VISOR-CyTOF distinguishes myeloid, B, and naive and memory CD4 + and CD8 + T cells from tissues and blood. Immune cells from the tissues of PWH as described in panel (A) (B) and PBMCs from people without HIV (PWOH; N = 4 participants) (C) were phenotyped by VISOR-CyTOF and visualized by tSNE using all markers in the panel. (D and E) tSNE analysis using only VISOR markers of VISOR-CyTOF separates myeloid, B, and T cells from one another. Data from the tissues from PWH (D) and PBMCs from PWOH (E) are shown. In (B)–(E), overlaid tSNEs are shown on the left, while tSNEs separated out by each immune subset are shown on the right. Abbreviations: Tm, memory T cells; Tn, naive T cells.

    Journal: Cell reports

    Article Title: Anatomical, subset, and HIV-dependent expression of viral sensors and restriction factors

    doi: 10.1016/j.celrep.2024.115202

    Figure Lengend Snippet: (A) Spleen, lymph node (LN), gut, male reproductive tract, kidney, liver, bone marrow (BM), heart, and lung were harvested postmortem from antiretroviral therapy (ART)-treated people with HIV (PWH; N = 7) and analyzed by VISOR-CyTOF. Sample sizes for individual tissues are indicated. Total numbers of immune, myeloid, B cells, CD4 + T, and CD8 + T cells analyzed are shown. Created with BioRender.com . (B and C) VISOR-CyTOF distinguishes myeloid, B, and naive and memory CD4 + and CD8 + T cells from tissues and blood. Immune cells from the tissues of PWH as described in panel (A) (B) and PBMCs from people without HIV (PWOH; N = 4 participants) (C) were phenotyped by VISOR-CyTOF and visualized by tSNE using all markers in the panel. (D and E) tSNE analysis using only VISOR markers of VISOR-CyTOF separates myeloid, B, and T cells from one another. Data from the tissues from PWH (D) and PBMCs from PWOH (E) are shown. In (B)–(E), overlaid tSNEs are shown on the left, while tSNEs separated out by each immune subset are shown on the right. Abbreviations: Tm, memory T cells; Tn, naive T cells.

    Article Snippet: CD4 , Standard BioTools , Cat#3174004B; RRID:AB_3661864.

    Techniques:

    (A and B) VISORs are expressed at the highest and lowest levels in myeloid and B cells, respectively, with T cells exhibiting intermediate expression. Results from tissues of PWH (A) and PBMCs of PWOH (B) are shown. (C–E) VISOR expression patterns differ in CD4 + T cell subsets. VISORs are more weakly expressed in CD4 + Tem relative to Tcm across tissues of PWH (C). In LN of PWH, VISORs are highly expressed in CD4 + Tfh, Treg, and Tcm and lowly expressed in Tem, Ttm, and CD69 + Tm (D). In PBMCs of PWOH, VISORs are highly expressed in CD4 + Treg, Tfh, and Tcm and lowly expressed in Ttm and Tem; low VISOR expression among CD69 + Tm likely reflects their being activated cell instead of true Trm (E). For all heatmaps, color intensity (blue to red) denotes the column-normalized mean-scaled expression of each indicated VISOR within the indicated cell subset. Data were generated by unsupervised clustering. Abbreviations: CD4 + Tcm, CD4 + T central memory; CD4 + Tem, CD4 + T effector memory; CD4 + Ttm, CD4 + T transitional memory; CD4 + Tfh, CD4 + T follicular helper; CD4 + Treg, CD4 + T regulatory; CD4 + CD69 + Tm, CD69 + T memory as a proxy for T resident memory (Trm) cells.

    Journal: Cell reports

    Article Title: Anatomical, subset, and HIV-dependent expression of viral sensors and restriction factors

    doi: 10.1016/j.celrep.2024.115202

    Figure Lengend Snippet: (A and B) VISORs are expressed at the highest and lowest levels in myeloid and B cells, respectively, with T cells exhibiting intermediate expression. Results from tissues of PWH (A) and PBMCs of PWOH (B) are shown. (C–E) VISOR expression patterns differ in CD4 + T cell subsets. VISORs are more weakly expressed in CD4 + Tem relative to Tcm across tissues of PWH (C). In LN of PWH, VISORs are highly expressed in CD4 + Tfh, Treg, and Tcm and lowly expressed in Tem, Ttm, and CD69 + Tm (D). In PBMCs of PWOH, VISORs are highly expressed in CD4 + Treg, Tfh, and Tcm and lowly expressed in Ttm and Tem; low VISOR expression among CD69 + Tm likely reflects their being activated cell instead of true Trm (E). For all heatmaps, color intensity (blue to red) denotes the column-normalized mean-scaled expression of each indicated VISOR within the indicated cell subset. Data were generated by unsupervised clustering. Abbreviations: CD4 + Tcm, CD4 + T central memory; CD4 + Tem, CD4 + T effector memory; CD4 + Ttm, CD4 + T transitional memory; CD4 + Tfh, CD4 + T follicular helper; CD4 + Treg, CD4 + T regulatory; CD4 + CD69 + Tm, CD69 + T memory as a proxy for T resident memory (Trm) cells.

    Article Snippet: CD4 , Standard BioTools , Cat#3174004B; RRID:AB_3661864.

    Techniques: Expressing, Generated

    (A) In LN, restriction factor TRIM28, which blocks HIV integration, is lowly expressed in HIV-permissive CD4 + Tfh as compared to non-Tfh, while HIV transcription inhibitors (BRD4 and IFI16) and HIV translation inhibitors (IFITM1 and IFIT1) exhibit the opposite expression pattern. (B) In PBMCs, TRIM28, BRD4, IFI16, IFITM1, and IFIT1 are all more highly expressed in CD4 + Tfh as compared to non-Tfh. * p < 0.05, ** p < 0.01, as assessed using Student’s two-sided paired t test. Error bars correspond to SD. (C) Proposed model of restriction factor-mediated HIV latency in LN CD4 + Tfh. Low expression of TRIM28 in LN CD4 + Tfh facilitates HIV integration, while high levels of BRD4, IFI16, IFITM1, and IFIT1 limit HIV gene expression thereby promoting latency. Created with BioRender.com .

    Journal: Cell reports

    Article Title: Anatomical, subset, and HIV-dependent expression of viral sensors and restriction factors

    doi: 10.1016/j.celrep.2024.115202

    Figure Lengend Snippet: (A) In LN, restriction factor TRIM28, which blocks HIV integration, is lowly expressed in HIV-permissive CD4 + Tfh as compared to non-Tfh, while HIV transcription inhibitors (BRD4 and IFI16) and HIV translation inhibitors (IFITM1 and IFIT1) exhibit the opposite expression pattern. (B) In PBMCs, TRIM28, BRD4, IFI16, IFITM1, and IFIT1 are all more highly expressed in CD4 + Tfh as compared to non-Tfh. * p < 0.05, ** p < 0.01, as assessed using Student’s two-sided paired t test. Error bars correspond to SD. (C) Proposed model of restriction factor-mediated HIV latency in LN CD4 + Tfh. Low expression of TRIM28 in LN CD4 + Tfh facilitates HIV integration, while high levels of BRD4, IFI16, IFITM1, and IFIT1 limit HIV gene expression thereby promoting latency. Created with BioRender.com .

    Article Snippet: CD4 , Standard BioTools , Cat#3174004B; RRID:AB_3661864.

    Techniques: Expressing, Gene Expression

    (A) Fusion assay experimental design. PHA-stimulated, CCF2-loaded PBMCs ( N = 4) were mock-treated or incubated for 2 h with HIV-F4.HSA virions packaged with Blam-Vpr. Cleavage of CCF2 in HIV-fused cells by Blam-Vpr results in shift from green to blue fluorescence, detectable by FACS. Created with BioRender.com . (B) CCF2 profiles of uninfected and HIV-exposed cultures, which were sorted for unfused and HIV-fused cells and then analyzed by CyTOF-VISOR. Events were pre-gated on live, singlet cells. Gating strategy in . (C and D) tSNE plots of unfused and HIV-fused CD4 + Tm (C) or myeloid (D) cells analyzed by VISOR-CyTOF, highlighting dissimilarity of HIV-fused cells to their unfused counterparts. tSNE plots were generated using all markers in the CyTOF panel. (E and F) HIV-fused CD4 + Tm and myeloid cells express low levels of multiple VISORs, relative to their unfused counterparts. HIV-fused CD4 + Tm (E) and myeloid (F) cells lowly express sensors of HIV capsid (PQBP1 and MX2), RNA (RIGI), and DNA (AIM2, cGAS, and pIRF3). Additionally, HIV DNA sensor IFI16 is lowly expressed in HIV-fused CD4 + Tm (E), while HIV DNA sensors TLR9 and pSTING are lowly expressed in HIV-fused myeloid cells (F). With regards to restriction factors, HIV-fused CD4 + Tm express low levels of factors targeting HIV reverse transcription (SAMHD1 and PAF1), nuclear import (MX2), integration (TRIM28), transcription (TRIM28, IFI16, and BRD4), and translation (IFITM1) (E). HIV-fused myeloid cells express low levels of restriction factors targeting HIV nuclear import (MX2), transcription (BRD4), and translation (IFITM1) (F). (G) HIV-fused myeloid cells express high levels of SAMHD1 and TRIM28. The phosphorylated and inactive form of SAMHD1 (pSAMHD1) exhibits the opposite expression pattern. (H and I) HIV-fused and unfused cells express equivalent levels of HIV receptor and co-receptor. Mean expression levels of CD4 and CCR5 in unfused and HIV-fused CD4 + Tm (H) and myeloid (I) cells. * p < 0.05, ** p < 0.01, *** p < 0.001, n.s., non-significant, as assessed using Student’s two-sided paired t tests. Error bars correspond to SD.

    Journal: Cell reports

    Article Title: Anatomical, subset, and HIV-dependent expression of viral sensors and restriction factors

    doi: 10.1016/j.celrep.2024.115202

    Figure Lengend Snippet: (A) Fusion assay experimental design. PHA-stimulated, CCF2-loaded PBMCs ( N = 4) were mock-treated or incubated for 2 h with HIV-F4.HSA virions packaged with Blam-Vpr. Cleavage of CCF2 in HIV-fused cells by Blam-Vpr results in shift from green to blue fluorescence, detectable by FACS. Created with BioRender.com . (B) CCF2 profiles of uninfected and HIV-exposed cultures, which were sorted for unfused and HIV-fused cells and then analyzed by CyTOF-VISOR. Events were pre-gated on live, singlet cells. Gating strategy in . (C and D) tSNE plots of unfused and HIV-fused CD4 + Tm (C) or myeloid (D) cells analyzed by VISOR-CyTOF, highlighting dissimilarity of HIV-fused cells to their unfused counterparts. tSNE plots were generated using all markers in the CyTOF panel. (E and F) HIV-fused CD4 + Tm and myeloid cells express low levels of multiple VISORs, relative to their unfused counterparts. HIV-fused CD4 + Tm (E) and myeloid (F) cells lowly express sensors of HIV capsid (PQBP1 and MX2), RNA (RIGI), and DNA (AIM2, cGAS, and pIRF3). Additionally, HIV DNA sensor IFI16 is lowly expressed in HIV-fused CD4 + Tm (E), while HIV DNA sensors TLR9 and pSTING are lowly expressed in HIV-fused myeloid cells (F). With regards to restriction factors, HIV-fused CD4 + Tm express low levels of factors targeting HIV reverse transcription (SAMHD1 and PAF1), nuclear import (MX2), integration (TRIM28), transcription (TRIM28, IFI16, and BRD4), and translation (IFITM1) (E). HIV-fused myeloid cells express low levels of restriction factors targeting HIV nuclear import (MX2), transcription (BRD4), and translation (IFITM1) (F). (G) HIV-fused myeloid cells express high levels of SAMHD1 and TRIM28. The phosphorylated and inactive form of SAMHD1 (pSAMHD1) exhibits the opposite expression pattern. (H and I) HIV-fused and unfused cells express equivalent levels of HIV receptor and co-receptor. Mean expression levels of CD4 and CCR5 in unfused and HIV-fused CD4 + Tm (H) and myeloid (I) cells. * p < 0.05, ** p < 0.01, *** p < 0.001, n.s., non-significant, as assessed using Student’s two-sided paired t tests. Error bars correspond to SD.

    Article Snippet: CD4 , Standard BioTools , Cat#3174004B; RRID:AB_3661864.

    Techniques: Single Vesicle Fusion Assay, Incubation, Fluorescence, Generated, Reverse Transcription, Expressing

    (A) Productive infection assays experimental design. PHA-stimulated PBMCs ( N = 4) were mock-treated or exposed to HIV-F4.HSA for 3 days and then analyzed by VISOR-CyTOF. Analyses were performed on events corresponding to bystander or productively infected cells, which were defined based on the expression of long terminal repeat-driven reporter gene HSA. Gating strategies are shown in and . Created with BioRender.com . (B) Identification of productively infected cells by VISOR-CyTOF. Events were pre-gated on live, singlet, CD19 – CD8 – cells. (C and D) tSNE plots of bystander and productively infected CD4 + T (C) or myeloid (D) cells analyzed by VISOR-CyTOF, highlighting dissimilarity of bystander cells to their productively infected counterparts. tSNE plots were generated using all markers in the CyTOF panel. (E and F) Productively infected cells express high levels of VISORs relative to their bystander counterparts. Shown are viral sensors and restriction factors that are significantly elevated in productively infected CD4 + T (E) and myeloid (F) cells relative to their bystander counterparts. Viral sensors significantly upregulated in productively infected CD4 + T and myeloid cells were capsid sensors (PQBP1 and MX2) and DNA sensors (TLR9, AIM2, IFI16, cGAS, and pIRF3). In productively infected CD4 + T but not myeloid cells, HIV RNA sensors RIGI and pSTING were upregulated. Restriction factors upregulated in both productively infected CD4 + T and myeloid cells were those blocking HIV reverse transcription (SAMHD1 and PAF1), nuclear import (MX2), integration (TRIM28), transcription (TRIM28, IFI16, and BRD4), and translation (IFITM1). Productively infected CD4 + T but not myeloid cells also upregulated inactive pSAMHD1. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, as assessed using Student’s two-sided paired t tests. Error bars correspond to SD.

    Journal: Cell reports

    Article Title: Anatomical, subset, and HIV-dependent expression of viral sensors and restriction factors

    doi: 10.1016/j.celrep.2024.115202

    Figure Lengend Snippet: (A) Productive infection assays experimental design. PHA-stimulated PBMCs ( N = 4) were mock-treated or exposed to HIV-F4.HSA for 3 days and then analyzed by VISOR-CyTOF. Analyses were performed on events corresponding to bystander or productively infected cells, which were defined based on the expression of long terminal repeat-driven reporter gene HSA. Gating strategies are shown in and . Created with BioRender.com . (B) Identification of productively infected cells by VISOR-CyTOF. Events were pre-gated on live, singlet, CD19 – CD8 – cells. (C and D) tSNE plots of bystander and productively infected CD4 + T (C) or myeloid (D) cells analyzed by VISOR-CyTOF, highlighting dissimilarity of bystander cells to their productively infected counterparts. tSNE plots were generated using all markers in the CyTOF panel. (E and F) Productively infected cells express high levels of VISORs relative to their bystander counterparts. Shown are viral sensors and restriction factors that are significantly elevated in productively infected CD4 + T (E) and myeloid (F) cells relative to their bystander counterparts. Viral sensors significantly upregulated in productively infected CD4 + T and myeloid cells were capsid sensors (PQBP1 and MX2) and DNA sensors (TLR9, AIM2, IFI16, cGAS, and pIRF3). In productively infected CD4 + T but not myeloid cells, HIV RNA sensors RIGI and pSTING were upregulated. Restriction factors upregulated in both productively infected CD4 + T and myeloid cells were those blocking HIV reverse transcription (SAMHD1 and PAF1), nuclear import (MX2), integration (TRIM28), transcription (TRIM28, IFI16, and BRD4), and translation (IFITM1). Productively infected CD4 + T but not myeloid cells also upregulated inactive pSAMHD1. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, as assessed using Student’s two-sided paired t tests. Error bars correspond to SD.

    Article Snippet: CD4 , Standard BioTools , Cat#3174004B; RRID:AB_3661864.

    Techniques: Infection, Expressing, Generated, Blocking Assay, Reverse Transcription

    (A) Experimental design for HIV infection of cGAMP-stimulated PBMCs. PHA-stimulated PBMCs ( N = 3) were incubated for 20 h with cGAMP-containing viral-like particles (VLPs), or control VLPs harboring catalytically inactive cGAS mutant, and then analyzed by VISOR-CyTOF. In parallel, VLP-treated cells from the same donor were mock-infected or exposed to HIV-F4.HSA, cultured for 3 days, and monitored for infection rates. Created with BioRender.com . (B) cGAMP-treated CD4 + T cells exhibited elevated expression of HIV DNA sensors (AIM2, cGAS, and pIRF3), as well as restriction factors targeting reverse transcription (SAMHD1) and translation (IFITM1). By contrast, inactive pSAMHD1 trended lower among cGAMP-treated cells. * p < 0.05, ** p < 0.01, as assessed using Student’s two-sided paired t tests. (C and D) cGAMP-treated CD4 + T cells restrict HIV infection. Representative CyTOF plots of uninfected and infected PBMC cultures treated with control or cGAMP VLPs (C) and cumulative results from 4 independent donors (D). Results were pre-gated on live, singlet, CD19 – CD3 + CD8 – cells. * p < 0.05, ** p < 0.01; n.s., non-significant, as assessed using one-way repeated measures ANOVA followed by Tukey’s multiple comparisons test.

    Journal: Cell reports

    Article Title: Anatomical, subset, and HIV-dependent expression of viral sensors and restriction factors

    doi: 10.1016/j.celrep.2024.115202

    Figure Lengend Snippet: (A) Experimental design for HIV infection of cGAMP-stimulated PBMCs. PHA-stimulated PBMCs ( N = 3) were incubated for 20 h with cGAMP-containing viral-like particles (VLPs), or control VLPs harboring catalytically inactive cGAS mutant, and then analyzed by VISOR-CyTOF. In parallel, VLP-treated cells from the same donor were mock-infected or exposed to HIV-F4.HSA, cultured for 3 days, and monitored for infection rates. Created with BioRender.com . (B) cGAMP-treated CD4 + T cells exhibited elevated expression of HIV DNA sensors (AIM2, cGAS, and pIRF3), as well as restriction factors targeting reverse transcription (SAMHD1) and translation (IFITM1). By contrast, inactive pSAMHD1 trended lower among cGAMP-treated cells. * p < 0.05, ** p < 0.01, as assessed using Student’s two-sided paired t tests. (C and D) cGAMP-treated CD4 + T cells restrict HIV infection. Representative CyTOF plots of uninfected and infected PBMC cultures treated with control or cGAMP VLPs (C) and cumulative results from 4 independent donors (D). Results were pre-gated on live, singlet, CD19 – CD3 + CD8 – cells. * p < 0.05, ** p < 0.01; n.s., non-significant, as assessed using one-way repeated measures ANOVA followed by Tukey’s multiple comparisons test.

    Article Snippet: CD4 , Standard BioTools , Cat#3174004B; RRID:AB_3661864.

    Techniques: Infection, Incubation, Control, Mutagenesis, Cell Culture, Expressing, Reverse Transcription

    KEY RESOURCES TABLE

    Journal: Cell reports

    Article Title: Anatomical, subset, and HIV-dependent expression of viral sensors and restriction factors

    doi: 10.1016/j.celrep.2024.115202

    Figure Lengend Snippet: KEY RESOURCES TABLE

    Article Snippet: CD4 , Standard BioTools , Cat#3174004B; RRID:AB_3661864.

    Techniques: Virus, Recombinant, Electron Microscopy, Clinical Proteomics, Modification, Antibody Labeling, Staining, Software